Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FREEDOM Study: Perampanel Monotherapy in Untreated POS
NCT03201900Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2017
- Primary completion
- Feb 2019
- Modality
- Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of perampanel in focal onset seizure, sponsored by Eisai Co., Ltd.. Started Jun 2017; status: completed.
02
Drugs
perampanel
03
Conditions
focal onset seizure
Beyond the preview
Go deeper on NCT03201900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03201900.